Literature DB >> 9383633

Impaired lymphocyte proliferation in human acute pancreatitis.

R Pezzilli1, P Billi, E Beltrandi, M Casadei Maldini, R Mancini.   

Abstract

PURPOSE: We evaluated the proliferative response of lymphocytes to phytohemagglutinin P (PHA P), concanavalin A (Con A), and pokeweed mitogen (PWM) during the course of acute pancreatitis. PATIENTS AND METHODS: Sixty consecutive patients with acute pancreatitis were studied within 48 h of the onset of pain, and 16 of them were also studied 1 month after complete recovery. According to the Atlanta criteria, 21 patients had severe disease and 39 had mild disease. Fifteen healthy subjects and 11 patients with nonpancreatic acute abdomen were studied as controls. In 12 patients with acute pancreatitis the lymphocyte proliferation after stimulation with the three mitogens was also assessed in autologous and heterologous plasma.
RESULTS: The lymphocyte proliferative response to optimal doses of PHA P, Con A, and PWM was significantly lower (p < 0.001) in acute pancreatitis patients (mean +/- SD; PHA P 74,310 +/- 22,960 cpm; Con A 64,669 +/- 20,188 cpm; PWM 26,714 +/- 6,436 cpm) than in healthy subjects (PHA P 111,316 +/- 12,044 cpm; Con A 96,276 +/- 12,327 cpm; PWM 33,957 +/- 3,601 cpm). Patients with nonpancreatic acute abdomen had a significantly higher lymphocyte proliferative response to PHA P and Con A than acute pancreatitis patients (PHA P p < 0.002; Con A p < 0.01; PHA P 91,116 +/- 22,995 cpm; Con A 77,879 +/- 19,083 cpm). In patients with acute pancreatitis, lymphocyte proliferation stimulated with PHA P and Con A was significantly lower (PHA P p < 0.005; Con A p < 0.001) in those with severe disease (PHA P 63,190 +/- 15,157 cpm; Con A 52,813 +/- 13,324 cpm) than in those with mild disease (PHA P 80,298 +/- 24,340 cpm; Con A 71,052 +/- 20,490 cpm). In the group of 16 patients studied during the initial phase of acute pancreatitis and 1 month after recovery, lymphocyte proliferation significantly improved after remission of the disease but remained impaired compared with that of healthy subjects. No difference was found in the lymphocyte proliferation of the 12 patients with acute pancreatitis assayed in autologous and heterologous plasma.
CONCLUSIONS: The peripheral lymphocyte proliferative response to mitogen stimulation in patients with acute pancreatitis was decreased during the early phases of the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9383633     DOI: 10.1159/000201479

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  6 in total

1.  Immunosuppression in patients with severe acute pancreatitis.

Authors:  Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

2.  The prognostic value of the neutrophil-lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR.

Authors:  Aravind Suppiah; Deep Malde; Tameem Arab; Mazin Hamed; Victoria Allgar; Andrew M Smith; Gareth Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2013-02-01       Impact factor: 3.452

Review 3.  Pancreatitis in childhood.

Authors:  Mark E Lowe
Journal:  Curr Gastroenterol Rep       Date:  2004-06

4.  Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis.

Authors:  Tae Joo Jeon; Ji Young Park
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

5.  Value of neutrophil-lymphocyte ratio in evaluating response to percutaneous catheter drainage in patients with acute pancreatitis.

Authors:  Pankaj Gupta; Gaurav Chayan Das; Akash Bansal; Jayanta Samanta; Harshal S Mandavdhare; Vishal Sharma; Shano Naseem; Vikas Gupta; Thakur Deen Yadav; Usha Dutta; Neelam Varma; Manavjit Singh Sandhu; Rakesh Kochhar
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

6.  Growth factor mediated signaling in pancreatic pathogenesis.

Authors:  Debashis Nandy; Debabrata Mukhopadhyay
Journal:  Cancers (Basel)       Date:  2011-02-24       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.